tirzepatide cardiovascular outcomes trial results july 2025 Achieving BMI <25 kg/m2 was associated with reduced predicted risk of atherosclerotic disease in people with obesity or overweight on or placebo: a post hoc analysis of SURMOUNT-1, -3, and Can Dual Incretin Receptor Agonists
Description
Disclaimer: This article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment
Nouri is local, in all 50 states
It can activate glucose-dependent insulinotropic polypeptide receptors (GIP) and glucagon-like peptide-1 receptor agonists (GLP-1)
Active Ingredient: Zepbound uses Tirzepatide as the active ingredient
Natural alternatives to Zepbound can support weight loss, but they do not work the same way as prescription GLP-1 medications
Aim to drink water often
